from Reuters: Health News https://ift.tt/2OtssYL
Wednesday, August 15, 2018
Wednesday, August 15, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States.

from Reuters: Health News https://ift.tt/2OtssYL
from Reuters: Health News https://ift.tt/2OtssYL
Related Posts:
LATEST HEALTH NEWSAstraZeneca said on Friday its immunotherapy drug Imfinzi did not meet the main goal of improving survival rates for patients with the most advanced form of lung cancer, putting pressure on its shares. from Reuters: Heal… Read More
LATEST HEALTH NEWSA second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer. … Read More
LATEST HEALTH NEWSKevin Love is one of the toughest players in the NBA but the embodiment of that type of masculinity is 'outdated' and 'dangerous' and stops men from seeking help for depression and anxiety, according to the Cleveland Cavalier… Read More
LATEST HEALTH NEWS(Reuters Health) - The death of a Dutch teen serves as a grim reminder of the dangers associated with inhaling common household products, such as spray-on deodorant, keyboard dusters and whipped cream. The 19-year-old's cardi… Read More
LATEST HEALTH NEWS(Reuters Health) - Even though there are still a lot of unknowns about the effects of marijuana exposure in the womb and from breast milk, research to date still suggests that pregnant and nursing women avoid cannabis, U.S. d… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment